FDA Approves First Contrast Agent for Adult Cardiac MR Imaging
Gadavist is an approved contrast agent for use in cardiac MR to assess perfusion and late gadolinium enhancement in less than one hour.
Gadavist is an approved contrast agent for use in cardiac MR to assess perfusion and late gadolinium enhancement in less than one hour.